Acute Tubular Necrosis Caused by Zoledronic Acid Infusion in a Patient With Osteoporosis

Am J Ther. 2021 Apr 29;29(1):e146-e148. doi: 10.1097/MJT.0000000000001380.

Authors

Chinmay Jani^{1

2}, Jordan Ueberroth^{1

2}, Stephanie Page^{1

2}, Shiv Sehra^{1

2

3}

Affiliations

¹ Department of Medicine, Mount Auburn Hospital, Cambridge, MA.
² Department of Medicine, Harvard Medical School, Boston, MA.
³ Division of Rheumatology, Mount Auburn Hospital, Cambridge, MA.

PMID: 34010158
DOI: 10.1097/MJT.0000000000001380

No abstract available

Publication types

Letter

MeSH terms

Bone Density Conservation Agents* / adverse effects
Diphosphonates / adverse effects
Humans
Infusions, Intravenous
Necrosis / chemically induced
Osteoporosis* / drug therapy
Zoledronic Acid / adverse effects

Substances

Bone Density Conservation Agents
Diphosphonates
Zoledronic Acid